Slingshot members are tracking this event:

DBV Technologies to report topline results from Phase 3 PEPITES of Viaskin Peanut in Peanut allergy in October 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
DBVT Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pepites Trial, Viaskin